PARIS QUADRIFOLIA (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)
Welcome to the PulseAid listing for the PARIS QUADRIFOLIA drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| NON-PROPRIETARY NAME: | PARIS QUADRIFOLIA |
| SUBSTANCE NAME: | PARIS QUADRIFOLIA |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-09-12 |
| END MARKETING DATE: | 0000-00-00 |
PARIS QUADRIFOLIA HUMAN OTC DRUG Details:
| Item Description | PARIS QUADRIFOLIA from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| LABELER NAME: | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3([hp_X]/1) |
| START MARKETING DATE: | 2015-09-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 15631-0330_47128fa6-2557-41b8-8968-37db79df84f1 |
| PRODUCT NDC: | 15631-0330 |
| APPLICATION NUMBER: | |
Other PARIS QUADRIFOLIA Pharmaceutical Manufacturers / Labelers:
